Plasma concentrations but not serum concentrations of brain-derived neurotrophic factor are related to pro-inflammatory cytokines in patients undergoing major abdominal surgery

Clinical Biochemistry

Volumn 45, Issue 9, 2012, Pages 631-636

  Chimienti, G ^a   Mezzapesa, A ^a   Rotelli, M T ^b   Lupo, L ^b   Pepe, G ^a  

^a Biotechnologies and Pharmacological Sciences ^*  (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Acute phase response; BDNF; Cytokines; Surgical stress

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL SURGERY; ADULT; AGED; ALLELE; ARTICLE; ASTROCYTE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MAJOR SURGERY; MALE; OBSERVATIONAL STUDY; PERIOPERATIVE PERIOD; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION;

ABDOMEN; ADULT; AGED; AGED, 80 AND OVER; BLOOD PLATELETS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CYTOKINES; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; PERIOPERATIVE PERIOD; PLASMA; PLATELET ACTIVATION; POLYMORPHISM, SINGLE NUCLEOTIDE; SERUM; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84861228812     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.02.025     Document Type: Article

References (37)

1. Huang E.J., Reichardt L.F. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 2001, 24:677-736.
2. Tirassa P., Manni L., Stenfors C., Lundeberg T., Aloe L. RT-PCR ELISA method for analysis of neutrophin mRNA expression in brain and peripheral tissues. J Biotechnol 2000, 84:259-272.
3. Kermani P., Hempstead B. BDNF: a newly described mediator of angiogenesis. Trends Cardiovasc Med 2007, 17:140-143.
4. Rosenfeld R.D., Zeni L., Haniu M., Talvenheimo J., Radka S.F., Bennett L., et al. Purification and isolation of brain-derived neurotrophic factor from human serum. Protein Expr Purif 1995, 6:465-471.
5. Pan W., Banks W.A., Fasold M.B., Bluth J., Kastin A.J. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 1998, 37:1553-1561.
6. Lommatzsch M., Zingler D., Schuhbaeck K., Schloetcke K., Zingler C., Schuff-Werner P., et al. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging 2005, 26:115-123.
7. Pliego-Rivero F.B., Bayatti N., Giannakoulopoulos K., Glover V., Bradford H.F., Stern G., et al. Brain-derived neurotrophic factor in human platelets. Biochem Pharmacol 1997, 54:207-209.
8. Fujimura H., Altar C.A., Chen R., Nakamura T., Nakahashi T., Kambayashi J.-I., et al. Brain-derived neurotrophic factor is stored in human platelets and released by agonistic stimulation. Thromb Haemost 2002, 87:728-734.
9. Radka S.F., Holst P.A., Fritsche M., Altar C.A. Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay. Brain Res 1996, 709:122-130.
10. Nakahashi T., Fujimura H., Altar C.A., Li J., Kambayashi J., Tandon N.N., et al. Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Lett 2000, 470(2):113-117.
11. Schulte-Herbruggen O., Nassenstein C., Lommatzsch M., Quarcoo D., Renz H., Braun A. Tumor necrosis factor-alpha and interleukin-6 regulate secretion of brain-derived neurotrophic factor in human monocytes. J Neuroimmunol 2005, 160:204-209.
12. Namura K., Hasegawa G., Egawa M., Matsumoto T., Kobayashi R., Yano T., et al. Relationship of serum brain-derived neurotrophic factor level with other markers of disease severity in patients with atopic dermatitis. Clin Immunol 2007, 122(2):181-186.
13. Kerschensteiner M., Gallmeier E., Behrens L., Leal V.V., Misgeld T., Klinkert W.E., et al. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?. J Exp Med 1999, 189:865-870.
14. Hohlfeld R., Kerschensteiner M., Stadelmann C., Lassmann H., Wekerle H. The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis. Neurol Sci 2006, 27(Suppl. 1):S1-S7.
15. Ikeda O., Murakami M., Ino H., Yamazaki M., Nemoto T., Koda M., et al. Acute up-regulation of brain-derived neurotrophic factor expression resulting from experimentally induced injury in the rat spinal cord. Acta Neuropathol 2001, 102:239-245.
16. Linker R.A., Lee D.H., Demir S., Wiese S., Kruse N., Siglienti I., et al. Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis. Brain 2010, 133(Pt 8):2248-2263.
17. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008, 9:46-56.
18. Chimienti G., Aquilino F., Rotelli M.T., Russo F., Lupo L., Pepe G. Lipoprotein(a), lipids and proinflammatory cytokines in patients undergoing major abdominal surgery. Br J Surg 2006, 93:347-353.
19. Saha R.N., Liu X., Pahan K. Up-regulation of BDNF in astrocytes by TNF-α: a case for the neuroprotective role of cytokine. J Neuroimmune Pharmacol 2006, 1:212-222.
20. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998, 102:1369-1376.
21. Sen S., Duman R., Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 2008, 64(6):527-532.
22. Copeland G.P., Jones D., Walters M. POSSUM: a scoring system for surgical audit. Br J Surg 1991, 78:355-360.
23. Vickers M.A., Green F.R., Terry C., Mayosi B.M., Julier C., Lathrop M., et al. Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res 2002, 53:1029-1034.
24. Karege F., Bondolfi G., Gervasoni N., Schwald M., Aubry J.M. Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 2005, 57:1068-1072.
25. Vutskits L., Lysakowski C., Czarnetzki C., Jenny B., Copin J.-C., Tramer M.R. Plasma concentrations of brain-derived neurotrophic factor in patients undergoing minor surgery: a randomized controlled trial. Neurochem Res 2008, 33:1325-1331.
26. Ebadi M., Bashir R.M., Heidrick M.L., Hamad F.M., Refaey H.E., Hamed A., et al. Neurotrophins and their receptors in nerve injury and repair. Neurochem Int 1997, 30:347-374.
27. Yamamoto H., Gurney M.E. Human platelets contain brain-derived neurotrophic factor. J Neurosci 1990, 10:3469-3478.
28. Wang Y., Wang J.-J., Zhao M.-Q., Liu S.-M., Li Y.-Z. Changes of serum brain-derived neurotrophic factor in children with obstructive sleep apnoea-hypopnoea syndrome following adenotonsillectomy. J IntMed Res 2010, 38:1942-1951.
29. Piccinni A., Marazziti D., Catena M., Domenici L., Del Debbio A., Bianchi C., et al. Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments. J Affect Disord 2008, 105:279-283.
30. Krabbe K.S., Mortensen E.L., Avlund K., Pedersen A.N., Pedersen B.K., Jorgensen T., et al. Brain-derived neurotrophic factor predicts mortality risk in older women. JAGS 2009, 57:1447-1452.
31. Anisman H. Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. Rev Psychiatry Neurosci 2009, 34:4-20.
32. Yon J.-H., Daniel-Johnson J., Carter L.B., Jevtovic-Todorovic V. Anesthesia induces neuronal cell death in the developing rat brain via the intrinsic and extrinsic apoptotic pathways. Neuroscience 2005, 35:815-827.
33. Lu L.X., Yon J.-H., Carter L.B., Jevtovic-Todorovic V. General anesthesia activates BDNF-dependent neuroapoptosis in the developing rat brain. Apoptosis 2006, 11:1603-1615.
34. Xi B., Wang C., Wu L., Zhang M., Shen Y., Zhao X., et al. Influence of physical inactivity on associations between single nucleotide polymorphisms and genetic predisposition to childhood obesity. Am J Epidemiol 2011, 173:1256-1262.
35. Gómez-Lázaro E., Arregi A., Beitia G., Vegas O., Azpiroz A., Garmendia L. Individual differences in chronically defeated male mice: behavioral, endocrine, immune, and neurotrophic changes as markers of vulnerability to the effects of stress. Stress 2011, 14:537-548.
36. Yoshimura R., Umene-Nakano W., Hoshuyama T., Ikenouchi-Sugita A., Hori H., Katsuki A., et al. Plasma levels of brain-derived neurotrophic factor and interleukin-6 in patients with dysthymic disorder: comparison with age- and sex-matched major depressed patients and healthy controls. Hum Psychopharmacol 2010, 25:566-569.
37. Desmet C.J., Peeper D.S. The neurotrophic receptor TrkB: a drug target in anti-cancer therapy?. Cell Mol Life Sci 2006, 63:755-759.